cryptocurrency simple explanation- Top See results about

Market News: US President-elect Trump's Middle East envoy met with the Saudi Crown Prince on Wednesday local time.China's economic restructuring and upgrading loan interest rates have remained at a historically low level, the financial sector has continued to exert its efforts to support the real economy, and credit resources have more flowed to key areas and weak links of the national economy. At the end of November, medium and long-term loans for manufacturing industry, loans for "specialized and innovative" enterprises, and small and micro loans for general benefit increased by 12.8%, 13.2% and 14.3% respectively, which were higher than the growth rates of various loans in the same period. China's economic structure has been transformed and upgraded, and the credit structure has been continuously optimized. (CCTV News)USGS: A 6.4-magnitude earthquake occurred 41km southeast of Molina, Chile.

Challenging the monopoly of Europe and America, Chinese and Indian manufacturers have laid out the track of diet pills. For some time, GLP-1 (glucagon-like peptide -1) diet pills have caught fire in the United States and other western countries, and gradually marched into emerging markets. At present, two major pharmaceutical companies, Novo Nordisk in Denmark and Lilly in the United States, occupy most of the market share in the field of GLP-1 diet pills, but other pharmaceutical companies are also actively deploying the track. In 2026, Novo Nordisk's patent on smeagoutide will expire in China and India, while the patent on liraglutide, the main effective ingredient of the previous generation of GLP-1 diet pills, has expired in China and India. The industry believes that China and India, as two emerging markets, have a strong momentum of innovation and development in the pharmaceutical industry of both countries, and have great potential in the GLP-1 diet pills track. The entry of Chinese and Indian pharmaceutical companies will make the international competition in the field of GLP-1 diet pills more intense. (Global Times) Market News: A 6.6-magnitude earthquake occurred in Moller, Chile.

 The latest research results support Harvard's discovery that Novo Nordisk's diet drug Ozempic is related to rare visual loss. The latest research shows that Novo Nordisk's best-selling diet drug Ozempic may increase the risk of a rare visual loss disease-nonarteritic anterior ischemic optic neuropathy (NAION). This finding supports similar findings published earlier by the Harvard team. A research team composed of the University of Southern Denmark, the Norwegian Institute of Public Health and the University of Copenhagen found that diabetic patients who used Ozempic were twice as likely to be diagnosed with NAION as other drugs. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.Many people were killed and injured in the explosion in Thailand. The reporter from the General Desk was informed that an explosion occurred at a festival in Umpan County, Thailand in the early morning of December 14th local time. According to local media reports, the explosion killed four people, including a 14-year-old child, and injured 48 others. The local police have arrived at the scene to investigate the case. (CCTV News)